Challenge Trials-Could Deliberate Coronavirus Exposure Hasten Vaccine Development? - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Challenge Trials-Could Deliberate Coronavirus Exposure Hasten Vaccine Development?

Rita Rubin

Author Information

PMID: 32496545 DOI: 10.1001/jama.2020.9881

No abstract text available.

COVID-19

COVID-19 Vaccines

Coronavirus Infections

Humans

Pandemics

Pneumonia, Viral

Randomized Controlled Trials as Topic

Viral Vaccines

Volunteers

COVID-19 Vaccines

Viral Vaccines

News

AIDS Activism and Coronavirus Vaccine Challenge Trials.Do coronavirus vaccine challenge trials have a distinctive generalisability problem?Human challenge trials in vaccine development.Considering human challenge trials for tuberculosis vaccine development.SARS coronavirus vaccine development.Text messages could hasten tuberculosis drug compliance.Diabetes could hasten MCI-to-AD conversion.Poll tax could hasten project 2000.Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174].Calls for human challenge vaccine trials.

Live unattenuated vaccines for controlling viral diseases, including COVID-19.Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness.